JanineV.KyrillosMDFACP

[Pronunciation: ker-rill-ose]

Obesity Medicine & Nutrition

Medical Director, Jefferson Comprehensive Weight Management

Dr. Kyrillos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
225 E City Ave
Suite 10
Bala Cynwyd, PA 19004
Phone+1 215-503-3838

Fax+1 610-664-0827

Dr. Janine Kyrillos is an associate professor of medicine at Sidney Kimmel Medical College at Thomas Jefferson University In Philadelphia and is board certified in Internal Medicine and Obesity Medicine. She received her MD from Rutgers Robert Wood Johnson Medical School. She treats obesity, diabetes, metabolic syndrome using lifestyle changes, low carb diet, fasting, and medication management.

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2002
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1999 - 2000
Rutgers Robert Wood Johnson Medical SchoolClass of 1999
University of PennsylvaniaBSN, 1983 - 1987

Top Doc Philadelphia Magazine, 2016-2023
Top Doctor Castle Connolly, 2013-2019
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2014
Join now to see all

PubMed

3 citations
Semaglutide 2.4-mg injection as a novel approach for chronic weight management.
Janine Kyrillos
The American Journal of Managed Care. 2022-12-01
1 citations
Integrating semaglutide into obesity management - a primary care perspective.
Janine V Kyrillos, Neil S Skolnik, Bhasha Mukhopadhyay, Nicholas Pennings
Postgraduate Medicine. 2022-01-01
Introducing an important therapy for obesity to primary care: once-weekly subcutaneous semaglutide 2.4 mg.
Janine V Kyrillos, Patrick M O'Neil, Sean Wharton
Postgraduate Medicine. 2022-01-01

Doctors Labelling New Weight Loss Drug a ‘Game Changer'March 7th, 2021
Good Fats, Bad Fats, and Why the Ketogenic Diet MattersJuly 13th, 2018
Losing Weight After Menopause Is Tough. Here Are Tips That May HelpMay 19th, 2017
Join now to see all